Xintela AB operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xintela AB with three other
miscellaneous service companies in Europe:
sales of 37,000.00 Norwegian Kroner [US$4,270.91 ]
(40,798.00 Polish New Zlotys [US$10,588.71 ]
Neurovive Pharmaceutical AB
(27,000.00 Swedish Kronor [US$2,913.03 ]
of which 100%